SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

It's intuitive that a robust immune response to COVID-19 will result in a less severe, even asymptomatic infection. A new study puts some numbers to the term "robust." The study, in 92 critically ill ...

The safety and efficacy of monoclonal antibody therapy with low-dose bamlanivimab plus etesevimab was similar to that of higher doses of the drug combination in patients with mild to moderate COVID-19 ...

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

A study by Chinese researchers has found the strongest evidence yet of an association between persistence of the SARS-CoV-2 virus and Long COVID. Not only was the presence of virus in tissues ...